Рет қаралды 594
This is a recording of a Code Information Session held in June 2024. It is designed to help our Industry to understand and apply the Medicines Australia Code of Conduct Edition 19, with regards to social media activity, media statements and influencers. This is the second Code info session focusing on social media, with the initial session being released in October 2022. It focuses on Section 11 and 13 of the Code and is presented by Sophie Seck, Medicines Australia’s Senior Manager for Ethics & Compliance, as part of our strategy to support application of the Code in practice, and is part of our series on Code Information Sessions which are available free and online.
0:00 Social Media - Part 2
6:01 Media platforms in the context of the Code
15:42 What can we promote on social media?
19:14 Clinical trial recruitment
22:11 Product specific comms - why or why not?
37:09 Writing and issuing media statements
1:01:56 International trends: complaints